Free Trial

Tryptamine Therapeutics (TYP) Insider Trading & Ownership

Tryptamine Therapeutics (ASX:TYP) Insider Buying and Selling Activity

Number Of
Insiders Buying
(Last 12 Months)
1
Amount Of
Insider Buying
(Last 12 Months)
$84,637.55
Number Of
Insiders Selling
(Last 12 Months)
0
Get TYP Insider Trade Alerts

Want to know when executives and insiders are buying or selling Tryptamine Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

TYP Insider Buying and Selling by Quarter

Tryptamine Therapeutics Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
6/14/2024Jason CarrollInsiderBuy604,738A$0.02A$12,094.76
6/6/2024Jason CarrollInsiderBuy1,692,514A$0.02A$35,542.79
6/3/2024Jason CarrollInsiderBuy1,000,000A$0.03A$25,000.00
5/30/2024Jason CarrollInsiderBuy500,000A$0.02A$12,000.00
5/1/2024Mark DaviesInsiderIssued2,000,000A$0.02A$40,000.00
(Data available from 1/1/2013 forward)

TYP Insider Trading Activity - Frequently Asked Questions

Who is on Tryptamine Therapeutics's Insider Roster?

The list of insiders at Tryptamine Therapeutics includes Jason Carroll, and Mark Davies. Learn more on insiders at TYP.

Which Tryptamine Therapeutics insiders have been buying company stock?

The following insider purchased TYP shares in the last 24 months: Jason Carroll (A$84,637.55).

How much insider buying is happening at Tryptamine Therapeutics?

Insiders have purchased a total of 3,797,252 TYP shares in the last 24 months for a total of A$84,637.55 bought.

Which Tryptamine Therapeutics insiders have been selling company stock?

The following insider sold TYP shares in the last 24 months: Mark Davies (A$40,000.00).


This page (ASX:TYP) was last updated on 7/1/2024 by MarketBeat.com Staff

From Our Partners